The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

GSK sacks 110 China staff in wake of drug bribery case - sources

Fri, 06th Mar 2015 19:04

By Ben Hirschler

LONDON, March 6 (Reuters) - Drugmaker GlaxoSmithKline, which was fined 3 billion yuan ($479 million) in Chinalast year for bribery, is dismissing 110 employees in thecountry for misconduct, people familiar with the matter said onFriday.

The British company confirmed it had taken disciplinaryaction against staff whose conduct contravened its values andcode of conduct but declined to specify the number involved. Themisconduct took place before mid-2013, GSK added in a statement.

The dismissals follow detailed investigations intowrongdoing by employees in the wake of the corruption scandal,which badly damaged the drugmaker's reputation and hit itsbusiness in a fast-growing emerging market.

"As we have previously said, we have increased ourmonitoring of expense claims and increased our complianceefforts. We also engaged an independent legal firm and externalconsultancies to review our operations in China," GSK said.

"Where evidence of misconduct has been found, we takeappropriate disciplinary action up to and including terminationof employment."

The company's annual report, published last week, hadalready revealed that the number disciplinary cases againststaff in China jumped to 652 in 2014 from 48 in 2013.

Chinese police first accused GSK of bribery in July 2013,alleging the firm had funnelled as much as 3 billion yuan totravel agencies to facilitate bribes to doctors and officials.

The Chinese action highlights how regulators in the countryare increasingly cracking down on corporate malpractice. GSK wasissued with its record fine -- exactly the same amount as thealleged bribery -- in September 2014.

A court in the southern city of Changsha also handedsuspended jail sentences to Mark Reilly, the former head of GSKin China, and four other GSK executives.

The case was the biggest corruption scandal to hit a foreigncompany in China since the Rio Tinto affair in 2009, whichresulted in four executives, including an Australian, beingjailed.

($1 = 6.2620 Chinese yuan renminbi) (Editing by Mark Potter)

Related Shares

More News
Today 15:19

London close: Stocks mixed after disappointing retail sales data

(Sharecast News) - London stocks closed with mixed results on Friday, influenced by earlier declines in the US and Asian markets, as investors reacted...

Today 08:55

LONDON MARKET OPEN: FTSE 100 falls; retail sales plunge in April

(Alliance News) - Stock prices in London opened lower on Friday, with sentiment hurt across the globe.

Today 08:36

TOP NEWS: GSK celebrates Illinois jury verdict in Valadez case

(Alliance News) - GSK PLC on Friday welcomed the jury verdict in the Valadez case in Illinois state court, which found in GSK's favour in the first Za...

Today 07:52

LONDON BRIEFING: UK retail sales fall amid wet April; Co-Op Bank deal

(Alliance News) - Stocks are called to open lower on Friday, following New York lower, as hopes of interest rate cuts have come into question.

Today 07:30

Jury rules in favour of GSK in Zantac trial

(Sharecast News) - A court in Illinois has ruled in favour of GSK in the first Zantac case to go to trial, the UK drugs giant confirmed on Friday.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.